Magnetic resonance elastography (MRE) is a promising technique for noninvasive assessment of fibrosis, a major determinant of outcome in nonalcoholic fatty liver disease (NAFLD). However, data in children are limited. The purpose of this study was to determine the accuracy of MRE for the detection of fibrosis and advanced fibrosis in children with NAFLD and to assess agreement between manual and novel automated reading methods. We performed a prospective, multicenter study of twodimensional (2D) MRE in children with NAFLD. MR elastograms were analyzed manually at two reading centers, and using a new automated technique. Analysis using each approach was done independently. Correlations were determined between MRE analysis methods and fibrosis stage. Thresholds for classifying the presence of fibrosis and of advanced fibrosis were computed and cross-validated. In 90 children with a mean age of 13.1 6 2.4 years, median hepatic stiffness was 2.35 kPa. Stiffness values derived by each reading center were strongly correlated with each other (r 5 0.83). All three analyses were significantly correlated with fibrosis stage (center 1, q 5 0.53; center 2, q 5 0.55; and automated analysis, q 5 0.52; P < 0.001). Overall cross-validated accuracy for detecting any fibrosis was 72.2% for all methods (95% confidence interval [CI], 61.8%-81.1%). Overall cross-validated accuracy for assessing advanced fibrosis was 88.9% (95% CI, 80.5%-94.5%) for center 1, 90.0% (95% CI, 81.9%-95.3%) for center 2, and 86.7% (95% CI, 77.9%-92.9%) for automated analysis. Conclusion: 2D MRE can estimate hepatic stiffness in children with NAFLD. Further refinement and validation of automated analysis techniques will be an important step in standardizing MRE. How to best integrate MRE into clinical protocols for the assessment of NAFLD in children will require prospective evaluation.
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Currently, the leading noninvasive imaging methods for assessing liver fibrosis are elastographic techniques that measure mechanical properties such as stiffness and stiffness-related parameters that are believed to be related to fibrosis. Existing techniques are either ultrasound-based (vibration-controlled transient elastography and point shear wave elastography) or magnetic resonance-based (magnetic resonance elastography [MRE]). Ultrasound-based techniques may be limited by anatomical factors such as obesity or narrow rib spacing. In adults with chronic liver disease, MRE has shown higher accuracy than ultrasoundbased elastography techniques for predicting fibrosis, particularly in adults with NAFLD. (19) (20) (21) (22) However, data on MRE in children are extremely limited, and there have been no studies that focused on the performance of MRE in pediatric NAFLD.
MRI Assessment Guiding NAFLD Evaluation and Treatment (MAGNET) was a multicenter study that was developed as an ancillary study to the National Institute of Diabetes and Digestive and Kidney Diseases NASH Clinical Research Network (CRN). The primary aim of MAGNET was to develop magnetic resonance (MR)-based biomarkers in children with NAFLD to provide high accuracy for noninvasive assessment of the histological lesions of NAFLD. The current study is the first report from MAGNET and had the following aims in children with known or suspected NAFLD: (1) to assess interreader agreement and correlation between reading centers and methods for MRE-estimated hepatic stiffness; (2) to assess the correlation between MRE-estimated hepatic stiffness and histologic fibrosis stage; and (3) to determine the accuracy of MRE-estimated hepatic stiffness for detection of any fibrosis (i.e., for differentiating stage 1 from stage 0) and of advanced fibrosis (i.e., for differentiating stage 3 from stage < 3).
Materials and Methods

STUDY COHORT
MAGNET was a multisite, prospective, observational, cross-sectional ancillary study to the NASH CRN enrolling children with known or suspected NAFLD who had or were scheduled to have a liver biopsy. The determination to perform liver biopsy was a clinical decision and not part of this study. All children were age 8-17 years and were enrolled in the NASH CRN at the University of California, San Diego or Texas Children's Hospital. Exclusion criteria were extreme claustrophobia, pregnancy, weight exceeding scanner table limit, girth exceeding scanner bore diameter, or other contraindications to MR (e.g., metal in the eyes, implanted electronic devices, aneurysm clips, pacemaker, and cochlear implants). The parents or legal guardians of all subjects provided written informed consent. Assent was obtained from all children. The protocol was approved by the institutional review boards of the University of California, San Diego, Rady Children's Hospital San Diego, Texas Children's Hospital, and Baylor College of Medicine. For this analysis, we included only those children enrolled in MAGNET who had MRE attempted within 6 months of liver biopsy.
CLINICAL DATA COLLECTION
Clinical data were obtained for each participant at a single fasting intake visit conducted at the Clinical and Translational Research Institute at the University of California, San Diego Medical Center or the Texas Children's Liver Center. Age and sex were recorded. Height was measured to the nearest tenth of a centimeter on a clinical stadiometer. Weight was measured on a clinical scale to the nearest tenth of a kilogram. Body mass index was calculated as weight in kilograms divided by height in meters squared. Phlebotomy was performed after a 12-hour overnight fast. Assays performed at local clinical laboratories included platelet count (cells/mL), alanine aminotransferase (U/L), aspartate aminotransferase (U/L), and gammaglutamyltransferase (U/L).
LIVER TISSUE EVALUATION
Liver tissue slides were stained in a central laboratory with hematoxylin and eosin and Masson's trichrome stains. The slides were reviewed and scored by members of the NASH CRN Pathology Committee, a panel of nine expert liver pathologists who interpreted each feature of NAFLD in consensus. The Pathology Committee was blinded to any clinical or demographic information. A diagnosis was assigned as (1) not NAFLD, (2) NAFLD but not NASH, (3) borderline zone 1 NASH, (4) borderline zone 3 NASH, or 5) definite NASH based on the aggregate presence, zonal location, and degree of the individual histologic features of fatty liver disease. Although no single histologic feature is considered diagnostic of NASH, a typical set of minimum criteria includes zone 3 macrovesicular steatosis (>5%), lobular inflammation, and hepatocyte injury as manifest by ballooning in a pattern that is recognizable. Borderline cases demonstrated either a lesser degree of one or more findings, or an alteration of the pattern of NASH. A commonly found pediatric pattern of NAFLD is the borderline zone 1 (portal/periportal) pattern. (5) In addition to the diagnosis, an ordinal score was given for amounts of various histologic features, including, but not limited to, macrovesicular steatosis (0-3), lobular inflammation (0-2), and hepatocellular ballooning (0-2). The NAFLD activity score was calculated as the combination of steatosis, lobular inflammation, and hepatocellular ballooning on a scale of 0 to 8. 
MAGNETIC RESONANCE ELASTOGRAPHY MRE Acquisition
MRE was performed on a 3T MR scanner (Signa HDxt 3.0T (UCSD) or Signa Excite 3.0T (Methodist Hospital, Houston, TX, for subjects at Texas Children's Hospital/Baylor College of Medicine; GE Healthcare, Waukesha, WI) using a previously described technique. (23, 24) Children were instructed to fast for at least 4 hours before the MRE examination to reduce possible confounding physiological effects, and they were positioned supine and feet first with a torso phase-array surface coil centered at the level of the liver. A dielectric pad was placed anteriorly between the body wall and the surface coil. A passive acoustic driver was secured to the body wall anterior to the liver with an elastic band and continuous vibrations at 60 Hz were applied during data acquisition. The gradient-recalled echo MRE sequence incorporated the following parameters: repetition time 5 50 ms; echo time 5 20.2 ms; flip angle 5 30 8; matrix 5 256 3 64; field of view 5 36 3 36 to 48 3 48 cm, adjusted case by case by the technologist to accommodate body habitus; one-signal average; receiver bandwidth 5 631.25 kHz; array spatial sensitivity encoding technique with parallel imaging acceleration factor 2; and motion sensitization along the zdirection (superior to inferior) and four phase offsets. MRE data were acquired at four separate axial slices (10 mm thick, 10 mm interslice gap) at the widest transverse part of the liver, each with a 16-second breath-hold, resulting in total scan time of roughly 2 minutes including recovery periods between breathholds.
MRE Processing
Using a previously described two-dimensional (2D) direct inversion algorithm, (23) the MR scanner computer automatically produced hepatic stiffness maps (called elastograms) from the acquired data; these maps display the spatial distribution of a hepatic stiffness parameter called the magnitude of the complex shear modulus. This processing also provided a confidence map for each elastogram with values ranging from 0 to 1, with 1 representing highly reliable hepatic stiffness estimates from the model. To obtain reliable hepatic stiffness values, a confidence mask was created by keeping only pixels with confidence values greater than 0.95. Wave images, elastograms, and confidence masks were generated automatically by the MR scanner computer; processing time was usually less than 2 minutes. Examinations with incomplete, unanalyzable, or unreliable data were recorded.
MRE READING CENTERS
MRE examinations were analyzed centrally in two reading centers, one located at the University of California, San Diego, CA (Reading Center 1) and one at Mayo Clinic, Rochester, MN (Reading Center 2). As discussed below, reading center 1 performed only manual MRE analyses, whereas reading center 2 performed both manual and automated analyses. All analyses were performed independently and blinded to all other data, including the results of the other analyses and liver histology.
Manual Analysis
MRE-generated elastograms, magnitude images, wave images, and confidence masks were transferred offline for manual analysis. Using a custom software package (MRE Quant, Mayo Clinic, Rochester, MN), image analysts from Reading Center 1 and 2 independently drew regions of interest (ROIs) on magnitude images, so as to include only liver parenchyma, avoiding edges of liver, large blood vessels, and bile ducts. ROIs were then colocalized to corresponding wave images and further modified to include only areas having clearly visualized, parallel propagating waves. Hepatic stiffness measurements were calculated based on averaged values within the intersection of manually drawn ROIs and confidence masks.
Automated Analysis
MRE images were also analyzed using an automated liver elasticity estimation algorithm developed at the Mayo Clinic. The algorithm uses known relative positions and intensities of the liver, background, and other tissues to calculate a liver mask from MRE magnitude images. Areas with sharp anatomical features in magnitude images, phase images, or elastograms are then removed from the ROI to avoid incorporating blood vessels, or partial volumes of blood vessels into the hepatic stiffness calculation. Finally, a confidence mask such as that used in manual analysis, but with a less strict cutoff of 0.9, was applied to remove areas with noisy wave data, and mean hepatic stiffness was calculated from the resulting ROIs. Analyses were fully automatic; no manual input or screening was required.
DATA ANALYSIS
Reasons for ineligibility of the excluded subjects were summarized. Demographic, clinical, and biopsy measures of the subjects included in the study were summarized descriptively. MR examinations with incomplete, unanalyzable, or unreliable MRE data were excluded. Bland-Altman analyses were performed pairwise for all three MRE analyses (reading center 1, reading center 2, and automated). Bland-Altman bias (mean of the paired differences) and its significance, standard deviation of the differences, and the limits of agreement (bias 6 1.96 3 standard deviation) were computed for each pair of methods. Spearman's rank correlations were computed pairwise for the three MRE analyses. The choice of Spearman's correlation was guided by the outliers in the data, which would have strongly influenced the results of a parametric Pearson's correlation or linear regression analysis (whereas Spearman's correlation is insensitive to outliers). Pairwise correlations were compared using Williams' test for dependent correlations sharing one variable. (25) Spearman's correlations were computed between fibrosis stages and each of the MRE methods. Receiver operating characteristic (ROC) curves for classifying no fibrosis (stage 0) versus any fibrosis (stage 1) and no or mild fibrosis (stage 2) versus advanced fibrosis (stage 3) were computed for each of the three MRE methods. Area under the ROC curve (AUROC) was computed for each MRE method and each classification. For each method and each classification, the classification threshold was chosen that provided highest sensitivity at a minimum of 90% specificity. The following diagnostic parameters were then calculated at that threshold: sensitivity, specificity, positive predictive value, negative predictive value, and total accuracy. Stratified 6-fold cross-validation was applied to obtain more accurate estimates of the performance of the three methods. Bootstrap-based tests were used to determine 95% confidence intervals around the AUROCs and all diagnostic parameters. AUROCs were compared pairwise using bootstrap-based tests. Figure 1 details the recruitment, inclusion, and exclusion of children for this study. We screened 121 children and found seven to be ineligible for MAGNET.
Results
STUDY POPULATION
Reasons for ineligibility were: weight too high (n 5 2), declined MRI (n 5 2), metal in the eye (n 5 1), and a parent who felt the child would not cooperate with the MRI examination (n 5 2). The remaining 114 children were enrolled in MAGNET. Of these, seven were scanned during a period in which the MRE software was temporarily not operational after a system upgrade; these children were excluded from the current analysis because MRE was not attempted. Of the 107 children in whom MRE was attempted, MRE was incomplete in five (5%) due to girth exceeding scanner bore (n 5 1), claustrophobia (n 5 1), difficulty with breath holding (n 5 1), or discomfort with the MRE passive driver (n 5 1). In one child, the data were not analyzable due to low signal-to-noise ratio that prevented wave motion from being detected. Twelve additional children had unreliable MRE data due to severe breathing artifacts (n 5 5), other severe imaging artifacts (n 5 2), and poor signal-to-noise ratio causing the ROI area to be too small for reliable measurement (n 5 5). Thus, the overall rate of failing to obtain reliable MRE data was 16% (17/107). There was no significant difference in age, sex, race, ethnicity, weight, or body mass index z score for children with reliable MRE data versus those with no or unreliable MRE data (Supporting Table  S1 ). Children with unreliable MRE data did have significantly more advanced fibrosis than children with reliable MRE data (Supporting Table S1 ). For the 90 children with reliable MRE data, demographics and clinical features are shown in Table 1 . The mean age was 13.1 6 2.4 years, and 73% of participants were boys.
Liver biopsy results of the 90 children showed that three had steatosis <5% and were determined to not have NAFLD. Of the 87 children with NAFLD, the overall diagnostic determinations were as follows: NAFLD but not NASH, 44% (38/87); borderline zone 3 pattern, 17% (15/87); borderline zone 1 pattern, 20% (17/87); and definite NASH, 20% (17/87). The distribution of fibrosis severity was as follows: 
INTERREADER COMPARISON OF MRE READINGS
The median 2D MRE hepatic stiffness value was 2.35 kPa (range, 1.81-9.67) for reading center 1 manual analysis, 2.35 kPa (range, 1.85-10.46) for reading center 2 manual analysis, and 2.31 kPa (range 1.74 to 9.65) for the automated analysis. Bland-Altman plots and scatterplots for each pair of methods are presented in Figure 2 . The stiffness values obtained from the manual analysis at reading centers 1 and 2 were similar, on average (Fig. 2c , bias 5 0.001, P 5 0.9606). However, the stiffness values obtained from the automated analysis were lower, on average, than the stiffness values obtained at reading centers 1 and 2 ( Fig. 2a and  2e ; bias, 0.074 and 0.073 kPa, respectively; P 5 0.0006 and 0.0335, respectively). As shown in Figure 2d , the 2D MRE stiffness values obtained from the manual analysis at reading centers 1 and 2 were strongly correlated with each other (r 5 0.83), but not identical. Each manual analysis was also compared against the automated analysis. The correlation between the reading center 1 manual analysis and the automated analysis (Fig. 2b) (q 5 0.90) was significantly higher than the correlation between the reading center 1 and reading center 2 manual analyses (q 5 0.83) or the correlation between the reading center 2 manual analysis and the automated analysis ( Fig. 2f ; q 5 0.79; Williams' test, P 5 0.0121 and P < 0.001, respectively. There was no significant difference in correlations between reading center 1 and reading center 2 or between reading center 1 and automated reading (P 5 0.0116).
MRE VERSUS LIVER HISTOPATHOLOGY
A representative example of an MRE-generated elastogram is shown for each fibrosis stage grade in Figure 3 . All three MRE analyses were significantly correlated overall with fibrosis stage (q 5 0.53 for reading center 1 manual analysis, q 5 0.55 for reading center 2 manual analysis and q 5 0.52 for automated analysis; all P < 0.001). Figure 4 shows a dot plot of shear stiffness for each participant sorted by fibrosis stage and reading approach. Of note, there was a significant correlation between alanine aminotransferase values and MRE stiffness values: q 5 0.35 (P 5 0.0008) for reading center 1, q 5 0.46 (P < 0.0001) for reading center 2, and q 5 0.31 (P 5 0.0033) for automated analysis. However, there was not a consistently significant correlation between NAFLD activity score and MRE stiffness values: q 5 0.13 (P 5 0.2337) for reading center 1, rho 5 0.27 (P 5 0.0101) for reading center 2, and rho 5 0.05 (P 5 0.6375) for automated analysis. Figure 5A shows ROC curves for distinguishing children without liver fibrosis (stage 0) from those with any liver fibrosis (stage 1). The AUROC for classifying presence of any fibrosis was not significantly different between reading center 1 manual analysis and reading center 2 manual analysis (0.77 versus 0.79; bootstrap P > 0.05). The best classification threshold at 90% specificity was 2.77 kPa for reading center 1 manual analysis and 2.70 kPa for reading center 2 manual analysis. The cross-validated diagnostic performance is shown in Table 2 . Sensitivities, negative predictive values, and overall accuracies tended to be low or modest at 90% specificity; because the thresholds were based on 90% specificity, positive predictive value was higher. The cross-validated overall accuracy was 72.2% (95% confidence interval [CI], 61.8%-81.1%) for both reading center 1 manual analysis and reading center 2 manual analysis.
Figure 5B shows ROC curves for the identification of advanced fibrosis (stage 3) in children with NAFLD. After the Bonferroni correction, the AUROC for classifying advanced fibrosis was borderline significantly higher for reading center 1 manual analysis than for reading center 2 manual analysis (0.93 versus 0.88; family-wise bootstrap P 5 0.05). There were no other significant differences between AUROCs. The best classification threshold at 90% specificity was 3.05 kPa for reading center 1 manual analysis and 3.03 kPa for reading center 2 manual analysis. The cross-validated diagnostic performance is shown in Table 2 . As for the detection of any fibrosis, sensitivities tended to be low at 90% specificity, and, given the low number of subjects with advanced fibrosis, the positive predictive values tended to be quite low. Because the thresholds were based on 90% specificity, specificity, the overall accuracy and negative predictive value were high. The cross-validated overall accuracy was 88.9% (95% CI, 80.5%-94.5%) for reading center 1 manual analysis and 90.0% (95% CI, 81.9%-95.3%) for reading center 2 manual analysis.
Discussion
In MAGNET, we performed a dual-center study of MRE in children with NAFLD and compared MRE- measured hepatic stiffness to liver histology fibrosis stage. Notwithstanding a relatively high technical failure rate, we demonstrated that MRE could be performed on most children with NAFLD, although it was not universally tolerated as currently performed. There was a detrimental effect of inadequate breathholding, even in those children who were able to complete their examinations. For those with reliable MRE data, the interreader agreement for liver stiffness was strong. We also demonstrated the potential for automated analysis of MRE data. Overall, the correlation between MRE estimated hepatic shear stiffness and liver fibrosis stage was good. Notably, MRE did not perform as well in children with NAFLD compared with previously reported studies in adults. (26, 27) These data substantially advance the knowledge base regarding MRE in children. In 2012, Binkovitz et al. (28) reported the initial experience with pediatric MRE: a case series of seven children with varied liver disease to demonstrate the potential feasibility of MRE in children. That same year, in a company report for consumers, Siegel et al. (29) reported that in six children with cystic fibrosis and four healthy controls, a cutoff of >3.38 kPa was both 100% sensitive and specific for the detection of cirrhosis. In 2014, Xanthakos et al. (30) presented a case series of 35 children with eight different chronic liver diseases and noted that a cutoff of 2.71 kPa had a sensitivity of 88% and specificity of 85% in the separation of fibrosis stages 0-1 from 2-4. Anecdotally, we have seen children referred to our Fatty Liver Clinic who have already had liver MRE performed at outside imaging centers along with interpretations about whether or not they have fibrosis based on cutoffs in clinical use for adults. The results of this study suggest that MRE cutoffs derived from adult studies may not be directly applicable to children with NAFLD. Therefore, clinicians should be careful in interpreting MRE results in children. Further studies are needed to develop and confirm standardized pediatric-based cutoffs that can transcend diseases and institutions.
Few studies have evaluated interreader variability of MRE-estimated hepatic stiffness. Those that have done so were performed only in adults, and mostly in those with viral hepatitis rather than NAFLD. The intraclass correlation coefficient ranged from 0.74 to 0.99. (31) (32) (33) (34) In MAGNET, we found a correlation of 0.83. It is the variability in the values between 2.0 and 3.0 kPa that is most critical to the accurate classification of fibrosis stage in children with NAFLD. As a biomarker for patients with NAFLD, MRE in children was similar to adults in the ability to detect any fibrosis but did not perform as well for detection of advanced fibrosis. In adults, large single-center studies have been performed in patients with NAFLD. Kim et al. (27) reported that in 142 adults with NAFLD, a cutoff of 4.15 kPa had a sensitivity of 0.85 and specificity of 0.93 for identifying advanced fibrosis. Loomba et al. (26) reported in 117 adults with NAFLD that for identifying any fibrosis, a cutoff of 3.02 kPa had a sensitivity of 0.55 and specificity of 0.91, and that for identifying advanced fibrosis a cutoff of 3.64 had a sensitivity of 0.86 and specificity of 0.91. Finally, in a large meta-analysis of 697 adults with heterogeneous liver disease including NAFLD, Singh et al. (35) reported that for identifying any fibrosis, a cutoff of 3.45 kPa had a sensitivity of 0.73 and a specificity of 0.79, and that for identifying advanced fibrosis a cutoff of 4.11 had a sensitivity of 0.85 and a specificity of 0.85.
The histologic features of NAFLD in children can differ from those seen in adults with NAFLD. Children tend to have higher steatosis grades, which conceivably could affect hepatic stiffness values, because fat tends to be softer than lean tissue. In children, fibrosis is typically portal-based, whereas in adults fibrosis classically begins in the centrilobular region. It
is not yet known how the locations and patterns of fibrosis affect hepatic stiffness. It is believed that fibrosis produces a lattice-like framework of struts that impart parenchymal rigidity; it is plausible that the intraparenchymal arrangement of the framework, in addition to the composition of the framework could alter observed hepatic stiffness.
The current dual-center study was notable for the large sample size of well-characterized children with NAFLD including liver histology evaluated in a standardized fashion by expert liver pathologists blinded to the clinical and imaging details. In addition, the MRE images were analyzed at two experienced centers to enable evaluation of interreader agreement. The study also incorporated a novel fully automated analysis method that minimizes subjectivity and operator dependence from the analysis; with further validation, this new method may provide a mechanism for objective high-throughput, centralized analysis clinical trials. The major limitation of this study was the large number of children who were unable to undergo MRE or for whom MRE did not produce an interpretable elastogram. In addition, spectrum bias-such as the small number of children with stage 3-4 fibrosis-may have introduced some error into the reported thresholds and diagnostic performance for the detection of advanced fibrosis. This was further complicated by the technical failure rate in children with stage 3-4 fibrosis. There were not any obvious clinical differences such as age contributing to differences in technical failure, nor are there any physics or engineering reasons to explain these differences. However, we cannot exclude that there are underlying differences in some children with greater fibrosis that made breath holding more difficult. Because the total sample size with advanced fibrosis was still relatively small, we caution against overinterpreting the significance of this occurrence. We do note that future studies of MRE in children should prospectively evaluate factors that are related to technical success or failure. Furthermore, the variable time interval between liver biopsy and MRE studies may have introduced an unknown degree of error. However, the time interval was relatively small for progression or regression of fibrosis.
In MAGNET, we demonstrated that MRE could be used to estimate hepatic stiffness in children with NAFLD. However, the results of this study did not show the degree of diagnostic performance reported in adult-based studies. This may be due, in part, to technical difficulties in children, which might be addressed with improved pediatric MRE sequences that do not require breath holding. Further technical development of MRE and other noninvasive quantitative imaging biomarkers of fibrosis in children with NAFLD remains a major need. The further refinement and validation of automated analysis techniques will be an important step in standardizing MRE. How to best integrate MRE into clinical and research protocols for the assessment of NAFLD in children will need prospective evaluation.
